Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€27.60

€27.60

-1.440%
-0.4
-1.440%
-

-

 
02.05.24 / Tradegate WKN: 889684 / Symbol: RYN / Name: Rayonier / Stock / Residential & Commercial REIT / Mid Cap /
Latest predictions
23.09.23
4.82%
26.08.23
2.04%
Your prediction

Rayonier Inc. Stock

We can see a decrease in the price for Rayonier Inc.. Compared to yesterday it has lost -€0.400 (-1.440%).

Pros and Cons of Rayonier Inc. in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Rayonier Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Rayonier Inc. -1.440% -2.128% -7.383% -1.429% -9.211% -8.609% -
Apollo Commercial Real Est. -0.080% -6.627% -7.045% 7.379% -14.685% -26.441% -44.872%
Xenia Hotels & Resorts Inc -0.770% -1.527% -4.444% 13.158% 4.878% -19.876% -34.143%
American Capital Agency 0.950% 0.046% -2.373% 2.371% -3.732% -41.535% -44.331%

Comments

Rayonier Inc. (NYSE: RYN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for RYN provided by MarketBeat
Show more

Rayonier Inc. (NYSE: RYN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for RYN provided by MarketBeat
Show more

News

3 Stocks About to Book Gains on Building Products Demand: https://www.marketbeat.com/logos/articles/med_20240404120253_3-stocks-about-to-book-gains-on-building-products.jpg
3 Stocks About to Book Gains on Building Products Demand

Investors often follow the latest trends in the U.S. economy and attempt to align their portfolios with the best industries, some of which could have a breakout in the coming months. The